Capital Power Corporation (TSX:CPX)

CTI BioPharma Ratios and Metrics

Market cap in millions CAD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	8,765	8,856	4,453	5,414	4,584	3,699
Market Cap Growth	68.14%	98.88%	-17.76%	18.12%	23.93%	2.26%
Enterprise Value	16,035	14,457	8,380	9,546	8,446	8,237
PE Ratio	19.17	13.32	6.27	54.69	104.18	45.11
PS Ratio	2.73	2.41	1.10	2.00	2.61	2.07
PB Ratio	1.89	1.94	1.40	2.20	1.60	1.26
P/FCF Ratio	-	119.67	44.98	21.40	18.71	12.62
P/OCF Ratio	-	7.74	5.42	5.79	5.29	6.05
EV/Sales Ratio	5.03	3.93	2.06	3.52	4.81	4.60
EV/EBITDA Ratio	14.79	10.95	5.18	11.49	9.98	9.35
EV/EBIT Ratio	28.43	17.38	7.92	33.38	26.73	19.99
EV/FCF Ratio	-	195.36	84.64	37.73	34.47	28.11
Debt / Equity Ratio	1.10	1.13	1.53	1.58	1.25	1.30
Debt / EBITDA Ratio	5.37	3.87	3.00	4.64	4.18	4.27
Debt / FCF Ratio	-	69.50	49.26	15.40	14.59	12.97
Quick Ratio	-	1.06	1.06	0.56	0.69	0.73
Current Ratio	-	1.44	1.29	0.76	0.98	1.01
Asset Turnover	-	0.31	0.38	0.28	0.20	0.21
Return on Equity (ROE)	-	18.07%	26.11%	4.81%	3.01%	4.31%
Return on Assets (ROA)	-	4.32%	6.21%	1.86%	2.20%	2.94%
Return on Capital (ROIC)	2.95%	5.85%	9.17%	2.79%	3.00%	3.83%
Return on Capital Employed (ROCE)	-	7.20%	11.60%	3.60%	4.00%	5.30%
Earnings Yield	4.61%	7.89%	16.71%	2.55%	2.14%	3.68%
Earnings Yield	4.61%	7.89%	16.71%	2.55%	2.14%	3.68%
FCF Yield	-	0.84%	2.22%	4.67%	5.34%	7.92%
Dividend Yield	4.49%	4.08%	6.84%	5.60%	6.49%	7.23%
Payout Ratio	-	40.06%	38.98%	214.49%	223.47%	177.94%
Buyback Yield / Dilution	-209.35%	-10.02%	-0.20%	-3.91%	-6.57%	-0.80%
Total Shareholder Return	-204.86%	-5.94%	6.64%	1.69%	-0.08%	6.43%

Source: S&P Global Market Intelligence. Utility template. Financial Sources.